Clinical Trial Update: Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating bronchoprotection from levosalbutamol versus racemic salbutamol in asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Levosalbutamol (levosalbutamol)
• Racemic Salbutamol (salbutamol)

Snippet

Sponsor: University of Dundee | Conditions: Asthma | Phase 4 | Status: WITHDRAWN